File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Preventing And Treating Chronic Disorders Using The Modified Vaccination Technique.

TitlePreventing And Treating Chronic Disorders Using The Modified Vaccination Technique.
Authors
KeywordsBarabas, A.Z.
Department Of Surgery, University Of Calgary Health Sciences Centre, Calgary, Alberta, Canada.,
Email:Barabas@Ucalgary.Ca © Medline® Is The Source For The Citation And Abstract Of This Record.
Issue Date2009
Citation
Frontiers In Bioscience : A Journal And Virtual Library, 2009, v. 14, p. 3892-3898 How to Cite?
AbstractIt Is Anticipated That The Ultimate Solution For The Prevention And Termination Of Autoimmune Disorders Will Be Based On Somehow Manipulating The Cells Of The Immune System To Attain Antigen (Ag) Specific Downregulation And Termination. In The Last Few Years We Have Developed A New Vaccination Technique That We Call "Modified Vaccination Technique" (Mvt). It Has With Equal Effectiveness Both Prevented And Terminated Autoimmune Disease Causing Events In An Experimental Autoimmune Kidney Disease Model. We Expect That Our Technique Will Be Similarly Applicable To The Specific Treatment And Cure Of Numerous Other Chronic Disorders Presently Treated Only By Drugs. The Vaccine Is Composed Of Two Components, An Ag And A Specific Antibody Against It. When These Are Combined At Slight Ag Excess They Constitute A Vaccine Which Is Capable Of Treating Chronic Ailments By Redirecting Immune Response Outcomes In The Vaccinated Host. Both Components, Like Drugs, Will Have To Be Produced Ex Vivo In Order To Maintain Uniformity, Safety, Efficacy, And Specificity.
Persistent Identifierhttp://hdl.handle.net/10722/132549
ISSN
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorBarabas, AZen_US
dc.contributor.authorWeir, DMen_US
dc.contributor.authorCole, CDen_US
dc.contributor.authorBarabas, ADen_US
dc.contributor.authorBahlis, NJen_US
dc.contributor.authorGraeff, RMen_US
dc.contributor.authorLafreniere, Ren_US
dc.date.accessioned2011-03-28T09:26:12Z-
dc.date.available2011-03-28T09:26:12Z-
dc.date.issued2009en_US
dc.identifier.citationFrontiers In Bioscience : A Journal And Virtual Library, 2009, v. 14, p. 3892-3898en_US
dc.identifier.issn1093-4715en_US
dc.identifier.urihttp://hdl.handle.net/10722/132549-
dc.description.abstractIt Is Anticipated That The Ultimate Solution For The Prevention And Termination Of Autoimmune Disorders Will Be Based On Somehow Manipulating The Cells Of The Immune System To Attain Antigen (Ag) Specific Downregulation And Termination. In The Last Few Years We Have Developed A New Vaccination Technique That We Call "Modified Vaccination Technique" (Mvt). It Has With Equal Effectiveness Both Prevented And Terminated Autoimmune Disease Causing Events In An Experimental Autoimmune Kidney Disease Model. We Expect That Our Technique Will Be Similarly Applicable To The Specific Treatment And Cure Of Numerous Other Chronic Disorders Presently Treated Only By Drugs. The Vaccine Is Composed Of Two Components, An Ag And A Specific Antibody Against It. When These Are Combined At Slight Ag Excess They Constitute A Vaccine Which Is Capable Of Treating Chronic Ailments By Redirecting Immune Response Outcomes In The Vaccinated Host. Both Components, Like Drugs, Will Have To Be Produced Ex Vivo In Order To Maintain Uniformity, Safety, Efficacy, And Specificity.en_US
dc.languageengen_US
dc.relation.ispartofFrontiers In Bioscience : A Journal And Virtual Libraryen_US
dc.subjectBarabas, A.Z.en_US
dc.subjectDepartment Of Surgery, University Of Calgary Health Sciences Centre, Calgary, Alberta, Canada.,en_US
dc.subjectEmail:Barabas@Ucalgary.Ca © Medline® Is The Source For The Citation And Abstract Of This Record.en_US
dc.titlePreventing And Treating Chronic Disorders Using The Modified Vaccination Technique.en_US
dc.typeArticleen_US
dc.identifier.emailGraeff, Richard Milton:graeffr@hku.hken_US
dc.identifier.authorityGraeff, Richard Milton=rp01464en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.2735/3498-
dc.identifier.pmid19273320-
dc.identifier.scopuseid_2-s2.0-63849258872en_US
dc.identifier.volume14en_US
dc.identifier.spage3892en_US
dc.identifier.epage3898en_US
dc.identifier.isiWOS:000270060800014-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats